At present the clinical treatment of prostate cancer is based on clinical staging, cell deterioration, and patient circumstances, mainly surgery, radiation therapy, hormonal therapy, chemotherapy, immune therapy and freezing treatment.

Below is the summary of prostate cancer cure tablets at present: 1.An androgen receptor blocker Androgen receptor antagonist is with endogenous androgens in the target cells to compete with the combination of DHT receptors, inhibiting androgen into the nucleus, with blocking its biological effects. Androgen receptor blockers is with ease of use, advantages, such as adverse reactions, which are widely used in clinical practice. 2 LHRH analogues LHRH analogues can suppress the release of pituitary acting on the Leydig cells, inhibition of luteinizing hormone and testosterone production, so that the blood fell to castration levels of testosterone. 3 vascular endothelial growth factor (VEGF) inhibitors, Bevacizumab is a VEGF inhibitor, mainly through the mechanism of action and in VEGF, with blocking it and in the endothelial cell surface receptors. It can reduce tumor angiogenesis so that tumor tissue could not obtain the necessary blood, oxygen and other nutrients and ultimately “starving to death” in order to achieve the anti-cancer effect. Adverse reactions are hypertension, neutropenia, stomatitis, congestive heart failure, vomiting, and diarrhea. 4 Immune therapy Dendreon’s Provenge is developing a cancer immunotherapy drug that works by stimulating the patient’s own immune system to fight prostate cancer. 5 chemotherapy drugs Docetaxel by inhibiting cell division is necessary for tubulin and inhibit cancer cell division and proliferation ,serveral years ago FDA was approved docetaxel injection in combination with prednisone for the treatment of advanced metastatic prostate cancer. 6 Other prostate cancer cure tablets Calcitriol is the natural form of vitamin D, which is in the body to play through the generation of hydroxyl biological effects of chemotherapy drugs,which can increase the anti-tumor activity of the specific mechanism of action is unknown. Common adverse reactions are mainly neutropenia, and fatigue.